Skip to main content

Table 3 Association of SNPs with breast cancer risk in both testing and validation sets

From: Breast cancer risk assessment with five independent genetic variants and two risk factors in Chinese women

Genotype

Testing Set, TS.

(n= 1,779)

Validation Set, VS.

(n= 1,881)

Adjusted OR

(95% CI)a

P a

Adjusted OR

(95% CI)b

P b

Adjusted OR

(95% CI)c

P c

 

Case (%)

(n= 878)

Control (%)

(n= 900)

Cases (%)

(n= 914)

Controls (%)

(n= 967)

      

2q35: rs13387042

         

GG

627 (72.74)

695 (77.91)

712 (78.33)

773 (80.60)

1.00 (ref.)

 

1.00 (ref.)

 

1.00 (ref.)

 

GA

223 (25.87)

188 (21.08)

181 (19.91)

178 (18.56)

1.29 (1.03 to 1.63)

0.030

1.21 (0.93 to 1.56)

0.155

1.23 (1.04 to 1.46)

0.018

AA

12 (1.39)

9 (1.01)

16 (1.76)

8 (0.83)

1.46 (0.60 to 3.54)

0.407

2.56 (1.03 to 6.38)

0.044

1.95 (1.04 to 3.66)

0.037

GA/AA

235 (27.26)

197 (22.09)

197 (21.67)

186 (19.40)

1.30 (1.04 to 1.63)

0.023

1.27 (0.99 to 1.63)

0.064

1.26 (1.07 to 1.49)

0.006

A allelic trend (Additive model)

  

1.30 (1.05 to 1.62)

0.017

1.21 (0.97 to 1.51)

0.085

1.25 (1.07 to 1.46)

0.004

3q24.1: rs2307032

         

CC

265 (30.78)

327 (37.16)

288 (31.58)

326 (34.42)

1.00 (ref.)

 

1.00 (ref.)

 

1.00 (ref.)

 

CT

436 (50.64)

398 (45.23)

429 (47.04)

464 (49.00)

1.31 (1.05 to 1.63)

0.016

1.09 (0.87 to 1.37)

0.459

1.20 (1.02 to 1.40)

0.027

TT

160 (18.58)

155 (17.61)

195 (21.38)

157 (16.58)

1.27 (0.95 to 1.69)

0.105

1.43 (1.06 to 1.91)

0.018

1.36 (1.11 to 1.66)

0.003

CT/TT

596 (69.22)

553 (62.84)

624 (68.42)

621 (65.58)

1.30 (1.06 to 1.60)

0.014

1.18 (0.95 to 1.46)

0.138

1.24 (1.07 to 1.44)

0.005

T allelic trend (Additive model)

  

1.11 (0.97 to 1.27)

0.122

1.17 (1.02 to 1.34)

0.025

1.14 (1.04 to 1.26)

0.006

6q22.33: rs2180341

         

AA

423 (49.76)

480 (54.55)

479 (52.64)

541 (56.53)

1.00 (ref.)

 

1.00 (ref.)

 

1.00 (ref.)

 

AG

373 (43.88)

334 (37.95)

380 (41.76)

350 (36.57)

1.29 (1.05 to 1.59)

0.016

1.26 (1.02 to 1.56)

0.033

1.28 (1.10 to 1.48)

0.001

GG

54 (6.35)

66 (7.50)

51 (5.60)

66 (6.90)

0.96 (0.64 to 1.43)

0.847

0.87 (0.57 to 1.32)

0.505

0.93 (0.70 to 1.24)

0.614

AG/GG

427 (50.24)

400 (45.45)

431 (47.36)

416 (43.47)

1.24 (1.01 to 1.51)

0.036

1.20 (0.97 to 1.47)

0.086

1.22 (1.06 to 1.40)

0.006

G allelic trend (Additive model)

  

1.10 (0.94 to 1.29)

0.222

1.06 (0.90 to 1.24)

0.496

1.08 (0.97 to 1.20)

0.174

6q25.1: rs2046210

         

GG

290 (33.68)

387 (43.48)

292 (32.19)

380 (39.58)

1.00 (ref.)

 

1.00 (ref.)

 

1.00 (ref.)

 

GA

413 (47.97)

393 (44.16)

460 (50.72)

443 (46.15)

1.46 (1.17 to 1.81)

6.31 × 10to 4

1.38 (1.10 to 1.73)

4.81 × 10-3

1.43 (1.23 to 1.67)

5.12 × 10-6

AA

158 (18.35)

110 (12.36)

155 (17.09)

137 (14.27)

2.05 (1.52 to 2.76)

2.95 × 10-6

1.54 (1.13 to 2.09)

5.76 × 10-3

1.79 (1.45 to 2.22)

7.13 × 10-8

GA/AA

571 (66.32)

503 (56.52)

615 (67.81)

580 (60.42)

1.59 (1.29 to 1.94)

8.52 × 10-6

1.42 (1.15 to 1.76)

1.27 × 10-3

1.51 (1.31 to 1.75)

2.40 × 10-8

A allelic trend (Additive model)

  

1.41 (1.22 to 1.62)

1.54E-06

1.24 (1.08 to 1.43)

2.27E-03

1.33 (1.20 to 1.46)

1.92E-08

10q26.13: rs2981582

         

CC

362 (41.51)

420 (46.88)

370 (41.29)

464 (48.95)

1.00 (ref.)

 

1.00 (ref.)

 

1.00 (ref.)

 

CT

400 (45.87)

388 (43.30)

420 (46.88)

408 (43.04)

1.25 (1.01 to 1.53)

3.85 × 10-2

1.20 (0.97 to 1.49)

9.84 × 10-2

1.24 (1.07 to 1.44)

4.40 × 10-3

TT

110 (12.61)

88 (9.82)

106 (11.83)

76 (8.02)

1.49 (1.07 to 2.08)

1.76 × 10-2

1.82 (1.27 to 2.62)

1.19 × 10-3

1.65 (1.29 to 2.10)

5.75 × 10-5

CT/TT

510 (58.49)

476 (53.13)

526 (58.71)

484 (51.05)

1.29 (1.06 to 1.57)

1.15 × 10-2

1.29 (1.05 to 1.59)

9.84 × 10-2

1.31 (1.14 to 1.50)

1.96 × 10-4

T allelic trend (Additive model)

  

1.23 (1.07 to 1.42)

0.005

1.30 (1.12-1.51)

0.0005

1.27 (1.15 to 1.41)

4.89E-06

  1. Results by logistic regression a in Testing Set, b in Validation Set, c in both Testing and Validation Set; a, b, c Adjust for age, age at menarche, menopausal status and age at first live birth.